Blood Pressure News and Research

RSS

Blood Pressure is the force of circulating blood on the walls of the arteries. Blood pressure is taken using two measurements: systolic (measured when the heart beats, when blood pressure is at its highest) and diastolic (measured between heart beats, when blood pressure is at its lowest). Blood pressure is written with the systolic blood pressure first, followed by the diastolic blood pressure (for example 120/80).

Cruciferous vegetables beat root vegetables in stabilizing blood sugar

The VEgetableS for vaScular hEaLth study reveals cruciferous vegetables improve glycemic control, emphasizing their importance in dietary strategies for health.

25 Sep 2025

University of Utah launches landmark study linking blood pressure and brain health

In six massive laboratory freezers at the University of Utah, nearly 40,000 blood samples wait in frozen stasis.

24 Sep 2025

Developing a wearable device to track deadly postpartum hemorrhage

In the delivery room, circumstances can turn dire on a dime if the patient starts losing excessive amounts of blood. One minute she seems fine, and the next, vital signs plummet, the patient crashes, and the care team may need to scramble for a blood transfusion or perform surgery.

24 Sep 2025

High levels of albumin in the urine linked to increased risk of dementia

A study shows that people with higher levels of the protein albumin in their urine are at increased risk of developing dementia. The study, led by researchers at Karolinska Institutet, is published in the scientific journal Journal of Internal Medicine.

24 Sep 2025

Uncontrolled hypertension claims more than 10 million lives every year

The World Health Organization (WHO) today released its second Global hypertension report, showing that 1.4 billion people lived with hypertension in 2024, yet just over one in five have it under control either through medication or addressing modifiable health risks.

24 Sep 2025

Trump claims ‘no downside’ to avoiding Tylenol during pregnancy. He’s wrong.

Obstetricians have long advised their pregnant patients that Tylenol is the safest option to reduce fever or pain. President Donald Trump stood before a national audience on Sept. 22 and contradicted that.

24 Sep 2025

Orforglipron pill improves heart and metabolic risk factors in trial

Patients taking an experimental oral GLP-1 drug lost significant weight and improved their heart and metabolic risk factors in a large, international, phase 3 clinical trial led by investigators at Weill Cornell Medicine, McMaster University, York University and other institutions.

22 Sep 2025

New eyedrop raises hopes for less invasive treatment of serious vision conditions

A new eyedrop has shown early success in delivering protective compounds to where they're needed most in the eye, raising hopes for less invasive treatment of serious vision conditions.

22 Sep 2025

Psychological distress after a heart attack emerges as a critical risk factor for heart health

Many people experience one or more types of psychological distress, including depression, anxiety, psychosocial stress or post-traumatic stress disorder (PTSD), after a heart attack, which can affect their physical recovery and long-term heart health, according to a new American Heart Association scientific statement, published today in the American Heart Association's flagship, peer-reviewed journal Circulation.

22 Sep 2025

Verapamil shows potential for preserving beta-cell function in type 1 diabetes

New research (the Ver-A-T1D trial) presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) (Vienna, 15-19 September) shows that slow-release (SR) verapamil (360mg daily) could have a potential effect on beta-cell function in adults with newly diagnosed type 1 diabetes.

18 Sep 2025

Oral GLP-1 drug orforglipron achieves significant weight loss in global trial

Patients taking an experimental oral GLP-1 drug lost significant weight and improved their heart and metabolic risk factors in a large, international, phase III clinical trial led by investigators at Weill Cornell Medicine, McMaster University, York University and other institutions

18 Sep 2025

Daily orforglipron GLP-1 pill achieves over 11% weight loss in global obesity trial

In a phase 3 trial, once-daily oral orforglipron induced significant, dose-dependent weight loss over 72 weeks in adults with obesity but no diabetes. It also improved multiple cardiometabolic markers with a safety profile similar to other GLP-1 receptor agonists.

18 Sep 2025

Cholesterol control improves but cardiovascular disease still increases in Mexico

Despite improved statin use and cholesterol control, cardiovascular disease risk rose in Mexico between 2016 and 2023, according to a study being presented at ACC Latin America 2025 that used region-specific tools to more accurately predict the local disease burden.

18 Sep 2025

Music therapy improves patient experience and outcomes in the cardiac ICU

Music therapy could significantly reduce heart rate, blood pressure and patient–ventilator asynchronies for patients admitted to the cardiac intensive care unit (ICU), according to research being presented at ACC Latin America 2025 taking place September 18-20 in Mexico City.

18 Sep 2025

Health care cuts threaten homegrown solutions to rural doctor shortages

Olivia Owlett chose to do her primary care residency in this Northern California college town largely because it faces many of the same health care challenges she grew up with.

18 Sep 2025

Implantable device helps stabilize blood pressure in spinal cord injury patients

Getting out of bed in the morning without the risk of passing out is a game-changer for 32-year-old Cody Krebs.

17 Sep 2025

Type 2 diabetes accelerates accumulation of chronic diseases across age groups

New research being presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Vienna (15-19 Sept), reveals type 2 diabetes (T2D) as a critical factor in chronic disease accumulation, particularly during the early stages.

17 Sep 2025

A new tool in the fight against obesity: Orforglipron's substantial weight loss results

New research presented at the Annual Meeting of the European Association for the Study of Diabetes in Vienna, Austria (Sept 15-19) and simultaneously published in NEJM shows that daily treatment with the new once-daily GLP-1 agonist orforglipron results in substantial weight loss in people living with obesity that do not have type 2 diabetes.

17 Sep 2025

Deep learning algorithm uses mammograms and age for heart disease prediction

A new machine learning model developed by The George Institute for Global Health can successfully predict heart disease risk in women by analyzing mammograms. The findings were published today in Heart, the official journal of the British Cardiovascular Society.

17 Sep 2025

Cleveland Clinic study shows lasting benefits of weight-loss surgery over GLP-1 medicines

A large Cleveland Clinic study has found that people with obesity and type 2 diabetes who undergo weight-loss surgery live longer and face fewer serious health problems compared with those treated with GLP-1 receptor agonist medicines alone.

16 Sep 2025

Blood Pressure News and Research

Further Reading

Cruciferous vegetables beat root vegetables in stabilizing blood sugar

University of Utah launches landmark study linking blood pressure and brain health

Developing a wearable device to track deadly postpartum hemorrhage

High levels of albumin in the urine linked to increased risk of dementia

Uncontrolled hypertension claims more than 10 million lives every year

Trump claims ‘no downside’ to avoiding Tylenol during pregnancy. He’s wrong.

Orforglipron pill improves heart and metabolic risk factors in trial

New eyedrop raises hopes for less invasive treatment of serious vision conditions

Psychological distress after a heart attack emerges as a critical risk factor for heart health

Verapamil shows potential for preserving beta-cell function in type 1 diabetes

Oral GLP-1 drug orforglipron achieves significant weight loss in global trial

Daily orforglipron GLP-1 pill achieves over 11% weight loss in global obesity trial

Cholesterol control improves but cardiovascular disease still increases in Mexico

Music therapy improves patient experience and outcomes in the cardiac ICU

Health care cuts threaten homegrown solutions to rural doctor shortages

Implantable device helps stabilize blood pressure in spinal cord injury patients

Type 2 diabetes accelerates accumulation of chronic diseases across age groups

A new tool in the fight against obesity: Orforglipron's substantial weight loss results

Deep learning algorithm uses mammograms and age for heart disease prediction

Cleveland Clinic study shows lasting benefits of weight-loss surgery over GLP-1 medicines

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News